Species distribution of Enterobacteriaceae and non-Enterobacteriaceae responsible for urinary tract infections at the Zainoel Abidin Hospital in Banda Aceh, Indonesia

##plugins.themes.bootstrap3.article.main##

SUHARTONO SUHARTONO
WILDA MAHDANI
ZINATUL HAYATI
NURHALIMAH NURHALIMAH

Abstract

Abstract. Suhartono S, Mahdani W, Hayati Z, Nurhalimah N. 2021. Species distribution of Enterobacteriaceae and non-Enterobacteriaceae responsible for urinary tract infections at the Zainoel Abidin Hospital in Banda Aceh, Indonesia. Biodiversitas 22: 3313-3318. Urinary tract infection (UTI) is an infection that occurs along the urinary tract caused by pathogenic bacteria. Enterobacteriaceae and non-Enterobacteriaceae are generally normal flora originating from the large intestine and vaginal mucosa. This study aimed to assess the distribution of Enterobacteriaceae and non -Enterobacteriaceae pathogens that cause UTI based on species diversity, patient age, gender, and hospital units, and to evaluate their antibiotic sensitivity to uropathogens in ZAH. In total, there were 284 isolates classified as UTI pathogens with 178 Enterobacteriaceae isolates dominated by Escherichia coli and 107 non- Enterobacteriaceae isolates. Non- Enterobacteriaceae consisted of 77 isolates of Gram-positive dominated by Enterococcus faecalis and Enterococcus facium, and 29 isolates of Gram-negative dominated by Acinetobacter baumannii. The highest UTI ratio was found in the elderly (56-65 years), namely 66.2% Enterobacteriaceae and 33.8% non-Enterobacteriaceae isolates. Based on gender, females were infected with Enterobacteriaceae (66.86%) and non-Enterobacteriaceae (37.41%). Most of UTI patients in the internal medicine unit were infected with Enterobacteriaceae (55.36%) and non-Enterobacteriaceae (44.64%). Amikacin, meropenem, and levofloxacin were antibiotics that had high sensitivity against Enterobacterial and non-Enterobacterial uropathogens. The emergence of Gram-positive uropathogens need to be concerned as these groups start emerging. It is also important to monitor regularly the antibiotic susceptibility of bacterial UTI pathogens to ensure the efficacy of current UTI treatments and minimize the UTI incidence in nosocomial settings.

##plugins.themes.bootstrap3.article.details##

References
Ahmad S, Hussain A, Khan MSA, Shakireen N, Ali I. 2020. Diabetes mellitus and urinary tract infection: Causative uropathogens, their antibiotic susceptibility pattern and the effects of glycemic status. Pak J Med Sci 36: 1550-1557.
Bientinesi, R, Murri R, Sacco E. 2020. Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis. Expert Opin Pharmacother 21: 637-644.
Burgos, RM, Biagi MJ, Rodvold KA, Danziger LH. 2018. Pharmacokinetic evaluation of meropenem and vaborbactam for the treatment of urinary tract infection. Expert Opin Drug Metab Toxicol 14: 1007-1021.
Cho S-Y, Choi S-M, Park SH, Lee D-G, Choi J-H, Yoo J-H. 2016. Amikacin therapy for urinary tract infections caused by extended-spectrum ?-lactamase-producing Escherichia coli. Korean J Intern Med 31: 156-161.
Foxman B, Barlow R, D'arcy H, Gillespie B, Sobel JD. 2000. Urinary tract infection: self-reported incidence and associated costs. Ann. Epidemiol. 10: 509-515.
Guglietta A. 2017. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiol 12: 239-246.
Kucheria RR. 2005. Urinary tract infections: New insights into a common problem. Postgrad Med J 81: 83-86.
Kurniawati H, Auliyanah A. 2021. Pattern of antibiotics use in adult patients with urinary tract infection (UTI). Berkala Kedokteran 17: 7-14. [Indonesian]
Matthews SJ, Lancaster JW. 2011. Urinary tract infections in the elderly population. Am J Geriatr Pharmacother 9: 286-309.
Mazzariol A, Bazaj A, Cornaglia G. 2017. Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review. J Chemother 29: 2-9.
Medina M, Castillo-Pino E. 2019. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol 1: 3-7.
Moroh J-L, Fleury Y, Tia H, Bahi C, Lietard C, Coroller L, Edoh V, Coulibaly A, Labia R, Leguerinel I. 2014. Diversity and antibiotic resistance of uropathogenic bacteria from Abidjan. Afr J Urol 20: 18-24.
Mulvey MA. 2002. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 4: 257-271.
Parameswarappa J, Basavaraj VP, Basavaraj CM. 2013. Isolation, identification, and antibiogram of Enterococci isolated from patients with urinary tract infection. Ann Afr Med 12: 176-181.
Pulcini C, Clerc-Urmes I, Attinsounon CA, Fougnot S, Thilly N. 2018. Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study. J Antimicrob Chemother 74: 775-781.
Rodriguez-Mañas L. 2020. Urinary tract infections in the elderly: a review of disease characteristics and current treatment options. Drugs Context 9: 2020-04-13.
Rostkowska OM, Kuthan R, Burban A, Sali?ska J, Ciebiera M, M?ynarczyk G, Durlik M. 2020. Analysis of susceptibility to selected antibiotics in Klebsiella pneumoniae, Escherichia coli, Enterococcus faecalis and Enterococcus faecium causing urinary tract infections in kidney transplant recipients over 8 years: single-center study." Antibiotics 9: 284.
Shiralizadeh S, Taghizadeh S, Asgharzadeh M, Shokouhi B, Gholizadeh P, Rahbar M, Kafil HS. 2018. Urinary tract infections: raising problem in developing countries. Rev Med Microbiol 29: 159-165.
Shrestha LB, Baral R, Poudel P, Khanal B. 2019. Clinical, etiological and antimicrobial susceptibility profile of pediatric urinary tract infections in a tertiary care hospital of Nepal. BMC pediatrics 19: 1-8.
Tenney J, Hudson N, Alnifaidy H, Li JTC, Fung KH. 2018. Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review. Saudi Pharm J 26: 678-684.
Yamasaki S, Shigemura K, Osawa K, Kitagawa K, Ishii A, Kuntaman K, Shirakawa T, Miyara T, Fujisawa M. 2021. Genetic analysis of ESBL-producing Klebsiella pneumoniae isolated from UTI patients in Indonesia. J Infect Chemother 27: 55-61.
Zhang Y, Wang L, Zhou C, Lin Y, Liu S, Zeng W, Yu K, Zhou T, Cao J. 2021. Unraveling mechanisms and epidemic characteristics of nitrofurantoin resistance in uropathogenic Enterococcus faecium clinical isolates. Infect Drug Resist 14: 1601-1611.

Most read articles by the same author(s)